Efficacy and Safety of Seltorexant as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Phase 2b, Randomized, Placebo-Controlled, Parallel-Group, Adaptive Dose-Finding Study

被引：0
|
作者：
Savitz, Adam [1 ]
Wajs, Ewa [1 ]
Zhang, Yun [1 ]
Xu, Haiyan [1 ]
Etropolski, Mila [1 ]
Saoud, Jay [1 ]
Luthringer, Remy [1 ]
Drevets, Wayne [1 ]
机构：
[1] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Adjunctive Therapy; Major Depressive Disorder (MDD); Orexin; Seltorexant;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M86
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study
    Savitz, Adam
    Wajs, Ewa
    Zhang, Yun
    Xu, Haiyan
    Etropolski, Mila
    Thase, Michael E.
    Drevets, Wayne C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (12): : 965 - 976
  • [2] Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial
    Askanase, Anca
    Berkani, Ouali
    Cahuzac, Clelia
    Cornelisse, Peter
    D'Cruz, David
    Kalunian, Kenneth
    Merrill, Joan
    Pozzobon, Marilia
    Navarra, Sandra
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3293 - 3297
  • [3] Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial
    Yamashita, Shizuya
    Fujita, Hitomi
    Yokota, Daisuke
    Morikawa-Isogai, Yuki
    Kitamoto, Ryuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [4] Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
    Thase, Michael E.
    Youakim, James M.
    Skuban, Aleksandar
    Hobart, Mary
    Augustine, Carole
    Zhang, Peter
    McQuade, Robert D.
    Carson, William H.
    Nyilas, Margaretta
    Sanchez, Raymond
    Eriksson, Hans
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (09) : 1224 - +
  • [5] Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Ebrecht, M.
    Sickmann, V
    Kungel, M.
    Werner, C.
    Marcus, R.
    McQuade, R.
    Modell, S.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 207 - 207
  • [6] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Berman, Robert M.
    Marcus, Ronald N.
    Swanink, Rene
    McQuade, Robert D.
    Carson, William H.
    Corey-Lisle, Patricia K.
    Khan, Arif
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 843 - 853
  • [7] Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial
    Mesens, Sofie
    Kezic, Iva
    van der Ark, Peter
    Etropolski, Mila
    Pandina, Gahan
    Benes, Heike
    Savitz, Adam
    Drevets, Wayne C.
    MOLECULAR PSYCHIATRY, 2024,
  • [8] Efficacy and Safety of Cariprazine as Adjunctive Therapy in Major Depressive Disorder: A Double-blind, Placebo-controlled Study
    Fava, Maurizio
    Durgam, Suresh
    Mergel, Victor
    Earley, Willie
    Nemeth, Gyoergy
    Laszlovszky, Istvan
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S352 - S353
  • [9] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder - A second multicenter, randomized, double-blind, placebo-controlled study
    Marcus, Ronald N.
    McQuade, Robert D.
    Carson, William H.
    Hennicken, Delphine
    Fava, Maurizio
    Simon, Jeffrey S.
    Trivedi, Madhukar H.
    Thase, Michael E.
    Berman, Robert M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 156 - 165
  • [10] EFFICACY AND SAFETY OF ADJUNCTIVE BREXPIPRAZOLE (OPC-34712) IN MAJOR DEPRESSIVE DISORDER (MDD): A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Thase, M. E.
    Hobart, M.
    Augustine, C.
    Youakim, J.
    Zhang, P.
    Hefting, N.
    McQuade, R. D.
    Carson, W.
    Nyilas, M.
    Sanchez, R.
    EUROPEAN PSYCHIATRY, 2014, 29
12345